William Guyer sold $322K of Corcept Therapeutics Incorporated (CORT)

Executed Jul 17 2025, disclosed Jul 21 2025, 4 days later.

Value, as filed

$322K

4,379 sh × $73.48

Executed

Jul 17 2025

the trade date, as filed

Disclosed

Jul 21 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

William Guyer Chief Development Officer profile →

William Guyer (Chief Development Officer) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales, 1 filed past the two-business-day deadline), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $1.8M of CORT (16,300 sh across 2 lots, as filed), executed Aug 10.

The name

CORT

Corcept Therapeutics Incorporated CORT · Healthcare · 103 filings in 24 months ticker →

Healthcare · Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe end…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by William Guyer in CORT

CORTSALE Corcept Therapeutics Incorporated $1.8M
16,300 sh across 2 lots
Exec Aug 10
Filed Aug 12 · 4:26 PM ET CORTSALE Corcept Therapeutics Incorporated $419K
3,700 sh × $113.12
Exec Aug 4
Filed Aug 6 · 6:44 PM ET CORTSALE Corcept Therapeutics Incorporated $1.8M
19,048 sh × $93.11
Exec Jul 7
Filed Jul 8 · 7:54 PM ET CORTSALE Corcept Therapeutics Incorporated $1.4M
20,000 sh × $70.60
Exec Jun 2
Filed Jun 4 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $1.0M
20,000 sh × $51.83
Exec May 5
Filed May 7 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $819K
20,000 sh × $40.97
Exec Apr 7
Filed Apr 8 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $424K
11,767 sh × $36.01
Exec Mar 20
Filed Mar 24 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $296K
8,233 sh × $35.99
Exec Mar 4
Filed Mar 6 · 5:30 PM ET